{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:06:01Z","timestamp":1788923161003,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01CA166379-06"],"award-info":[{"award-number":["2R01CA166379-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U44NS115111"],"award-info":[{"award-number":["U44NS115111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000046","name":"Abbott Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.wneu.2020.10.079","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:02:44Z","timestamp":1603166564000},"page":"e340-e347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing"],"prefix":"10.1016","volume":"145","author":[{"given":"Miriam M.","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Khazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Czerwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dentinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"DiMarzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gillogly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hadanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Argoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-9692","authenticated-orcid":false,"given":"Julie G.","family":"Pilitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.10.079_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.wneu.2020.10.079_bib2","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.wneu.2020.10.079_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/CON.0000000000000462","article-title":"Neuropathic pain","volume":"23","author":"Zilliox","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.wneu.2020.10.079_bib4","first-page":"22","article-title":"Implantable intrathecal pumps for chronic pain: highlights and updates","volume":"48","author":"Knight","year":"2007","journal-title":"Croat Med J"},{"key":"10.1016\/j.wneu.2020.10.079_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00006123-199902000-00026","article-title":"A\u00a0prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain","volume":"44","author":"Anderson","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2020.10.079_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pain.2004.01.003","article-title":"Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study","volume":"109","author":"Thimineur","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.wneu.2020.10.079_bib7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1526-4637.2012.01451.x","article-title":"Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain","volume":"13","author":"Hamza","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.wneu.2020.10.079_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1525-1403.2001.00121.x","article-title":"Long-term intrathecal ziconotide therapy: a case study and discussion","volume":"4","author":"Staats","year":"2001","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib9","first-page":"727","article-title":"Intrathecal therapy with ziconotide: clinical experience and considerations on its use","volume":"74","author":"Vitale","year":"2008","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.wneu.2020.10.079_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1570159X14666160210142056","article-title":"Ziconotide monotherapy: a systematic review of randomised controlled trials","volume":"15","author":"Brookes","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.wneu.2020.10.079_bib11","author":"McDowell"},{"key":"10.1016\/j.wneu.2020.10.079_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/papr.12599","article-title":"Effectiveness and safety of intrathecal ziconotide: interim analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)","volume":"18","author":"Deer","year":"2018","journal-title":"Pain Pract"},{"key":"10.1016\/j.wneu.2020.10.079_bib13","author":"Cosgrave"},{"key":"10.1016\/j.wneu.2020.10.079_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain","volume":"5","author":"Smith","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.wneu.2020.10.079_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/pme.12666","article-title":"The relationship between the mechanisms of action and safety profiles of intrathecal morphine and ziconotide: a review of the literature","volume":"16","author":"Webster","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/j.wneu.2020.10.079_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0304-3959(01)00463-8","article-title":"A\u00a0confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations","volume":"96","author":"Van Damme","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.wneu.2020.10.079_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pain.2004.11.003","article-title":"Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions","volume":"113","author":"Sullivan","year":"2005","journal-title":"Pain"},{"issue":"suppl 11","key":"10.1016\/j.wneu.2020.10.079_bib18","first-page":"S240","volume":"63","author":"Hawker","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.wneu.2020.10.079_bib19","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1097\/00007632-200011150-00017","article-title":"The Oswestry Disability Index","volume":"25","author":"Fairbank","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2020.10.079_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J\u00a0Pers Assess"},{"key":"10.1016\/j.wneu.2020.10.079_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/ner.12486","article-title":"Use of low dose ziconotide as first-line intrathecal monotherapy","volume":"20","author":"Prusik","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/neuros\/nyx153","article-title":"Establishing minimal clinically important difference of spinal cord stimulation therapy in post-laminectomy syndrome","volume":"81","author":"Paul","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2020.10.079_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.36076\/ppj.2011\/14\/15","article-title":"Italian registry on long-term intrathecal ziconotide treatment","volume":"14","author":"Raffaeli","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.wneu.2020.10.079_bib23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/ejp.1445","article-title":"Ziconotide for spinal cord injury-related pain","volume":"23","author":"Brinzeu","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.wneu.2020.10.079_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/pm\/pny132","article-title":"Intrathecal therapy for chronic pain: a review of morphine and ziconotide as firstline options","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.wneu.2020.10.079_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40120-015-0035-z","article-title":"Intrathecal ziconotide and morphine for pain relief: a case series of eight patients with refractory cancer pain, including five cases of neuropathic pain","volume":"4","author":"de la Calle Gil","year":"2015","journal-title":"Neurol Ther"},{"key":"10.1016\/j.wneu.2020.10.079_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ner.12392","article-title":"Intrathecal ziconotide: dosing and administration strategies in patients with refractory chronic pain","volume":"19","author":"McDowell","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/ner.12274","article-title":"Intrathecal pharmacology update: novel dosing strategy for intrathecal monotherapy ziconotide on efficacy and sustainability","volume":"18","author":"Pope","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ner.12270","article-title":"Ziconotide combination intrathecal therapy for noncancer pain is limited secondary to delayed adverse effects: a case series with a 24-month follow-up","volume":"18","author":"Hayek","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ner.12293","article-title":"Ziconotide trialing by intrathecal bolus injections: an open-label non-randomized clinical trial in postoperative\/posttraumatic neuropathic pain patients refractory to conventional treatment","volume":"18","author":"Backryd","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib31","first-page":"615","article-title":"Current perspectives on intrathecal drug delivery","volume":"7","author":"Bottros","year":"2014","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.wneu.2020.10.079_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2020.10.079_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.wneu.2020.10.079_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1525-1403.2007.00141.x","article-title":"Continuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12 months: a prospective, open-label study","volume":"11","author":"Ellis","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0253-7176.106012","article-title":"Pain catastrophizing: an updated review","volume":"34","author":"Leung","year":"2012","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.wneu.2020.10.079_bib37","first-page":"627","article-title":"Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain","volume":"7","author":"Saulino","year":"2014","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.wneu.2020.10.079_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.wneu.2020.10.079_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/ANA.0b013e31822ff779","article-title":"Long-term intrathecal drug administration for chronic nonmalignant pain","volume":"24","author":"Duarte","year":"2012","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"key":"10.1016\/j.wneu.2020.10.079_bib40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/papr.12438","article-title":"Clinical uses of intrathecal therapy and its placement in the pain care algorithm","volume":"16","author":"Pope","year":"2016","journal-title":"Pain Pract"},{"key":"10.1016\/j.wneu.2020.10.079_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/14656566.2019.1707182","article-title":"How has ziconotide impacted non-cancer pain management?","volume":"21","author":"Deer","year":"2020","journal-title":"Expert Opin Pharmacother"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020322713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020322713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:51:10Z","timestamp":1761814270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020322713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"alternative-id":["S1878875020322713"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.10.079","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.10.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}